Medplus Health Services · NSE: MEDPLUS · BSE: 543427
Q2 FY24 results · Jul–Sep 2023
Medplus Health Services reported revenue from operations of ₹1,408.59 crore (up 25.7% from Q2 FY23) and net profit of ₹14.54 crore (up 124.5% from Q2 FY23) for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,408.59 | 1,120.62 | +25.7% | 1,284.30 | +9.7% |
| Other income | 10.37 | 10.89 | −4.8% | 9.39 | +10.3% |
| Total income | 1,418.95 | 1,131.52 | +25.4% | 1,293.69 | +9.7% |
| Profit before tax | 16.44 | 8.82 | +86.4% | 5.05 | +225.6% |
| Net profit for the period | 14.54 | 6.48 | +124.5% | 3.77 | +286.3% |
| Attributable to shareholders of the company | 14.56 | 6.57 | +121.8% | 3.79 | +284.7% |
| EPS, basic (₹) | 1.22 | 0.55 | +121.8% | 0.32 | +281.2% |
| Net margin (%) | 1.0 | 0.6 | 0.3 |
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 98.67 | 42.45 | +132.4% | 71.89 | +37.3% |
| Other income | 1.76 | 4.26 | −58.6% | 1.81 | −2.3% |
| Total income | 100.44 | 46.72 | +115.0% | 73.70 | +36.3% |
| Profit before tax | (0.04) | (0.82) | Loss narrowed | (3.48) | Loss narrowed |
| Net profit for the period | (0.04) | (0.82) | Loss narrowed | (3.48) | Loss narrowed |
| EPS, basic (₹) | 0.05 | (0.07) | Turned profit | (0.29) | Turned profit |
| Net margin (%) | -0.0 | -1.9 | -4.8 |
Consolidated
- Filed with BSE
- 11 Nov 2023, 13:43 IST
- Board meeting
- 08 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Nov 2023, 13:43 IST
- Board meeting
- 08 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE